Literature DB >> 2043768

Carrier detection in Wiskott-Aldrich syndrome: combined use of M27 beta for X-inactivation studies and as a linked probe.

J Goodship1, J Carter, T Espanol, Y Boyd, S Malcolm, R J Levinsky.   

Abstract

Wiskott-Aldrich syndrome (WAS) is an X-linked immunodeficiency disorder with no clinical or immunologic abnormalities in carrier females. The defective gene has been localized to proximal Xp. Carrier females have nonrandom use of the X chromosome in granulocytes, lymphocytes, and monocytes. We have used the probe M27 beta, which detects both a variable number tandem repeat polymorphism and methylation differences between the active and inactive X chromosome, in the investigation of families referred for genetic counseling. M27 beta detects the locus DXS255, which is tightly linked to WAS. As the probe that is used for investigation of X-inactivation patterns is also linked to the disease locus, it is possible to assign phase in families where this could not be done by conventional use of linked probes. The mothers of four isolated male cases had nonrandom use of the X chromosome. A new mutation was identified in one family with two affected males.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2043768

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  8 in total

1.  X chromosome-inactivation patterns of 1,005 phenotypically unaffected females.

Authors:  James M Amos-Landgraf; Amy Cottle; Robert M Plenge; Mike Friez; Charles E Schwartz; John Longshore; Huntington F Willard
Journal:  Am J Hum Genet       Date:  2006-07-27       Impact factor: 11.025

Review 2.  Genetic control of X inactivation and processes leading to X-inactivation skewing.

Authors:  J W Belmont
Journal:  Am J Hum Genet       Date:  1996-06       Impact factor: 11.025

3.  Trisomy X in a female member of a family with X linked severe combined immunodeficiency: implications for carrier diagnosis.

Authors:  T Lester; M de Alwis; P A Clark; A M Jones; F Katz; R J Levinsky; C Kinnon
Journal:  J Med Genet       Date:  1994-09       Impact factor: 6.318

4.  Detection of new paternal dystrophin gene mutations in isolated cases of dystrophinopathy in females.

Authors:  E Pegoraro; R N Schimke; K Arahata; Y Hayashi; H Stern; H Marks; M R Glasberg; J E Carroll; J W Taber; H B Wessel
Journal:  Am J Hum Genet       Date:  1994-06       Impact factor: 11.025

Review 5.  Molecular detection of altered X-inactivation patterns in the diagnosis of genetic disease.

Authors:  S Malcolm
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

6.  Clonal analysis of human tumors with M27 beta, a highly informative polymorphic X chromosomal probe.

Authors:  M F Fey; H J Peter; H L Hinds; A Zimmermann; S Liechti-Gallati; H Gerber; H Studer; A Tobler
Journal:  J Clin Invest       Date:  1992-05       Impact factor: 14.808

Review 7.  Pyridoxine-refractory congenital sideroblastic anaemia with evidence for autosomal inheritance: exclusion of linkage to ALAS2 at Xp11.21 by polymorphism analysis.

Authors:  P E Jardine; P D Cotter; S A Johnson; E J Fitzsimons; L Tyfield; P W Lunt; D F Bishop
Journal:  J Med Genet       Date:  1994-03       Impact factor: 6.318

8.  A statistical measure for the skewness of X chromosome inactivation for quantitative traits and its application to the MCTFR data.

Authors:  Bao-Hui Li; Wen-Yi Yu; Ji-Yuan Zhou
Journal:  BMC Genom Data       Date:  2021-07-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.